Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19
Kow, Chia Siang; Hasan, Syed Shahzad.
Rev Esp Cardiol
; 74(2): 200-201, 2021.
Artigo em Inglês, Espanhol | MMyP | ID: biblio-1281397
Documentos relacionados
A review of the presentation and outcome of takotsubo cardiomyopathy in COVID-19.
Ketamine's love story with the heart: A Takotsubo twist.
Deleterious effects of catecholamine administration in acute heart failure caused by unrecognized Takotsubo cardiomyopathy.
Takotsubo syndrome is a coronary microvascular disease: experimental evidence.
Can longitudinal strain analysis differentiate between Takotsubo syndrome and acute coronary syndrome?
Daily longitudinal strain evaluation for left ventricular function monitoring in a 65-year-old female with reverse syndrome takotsubo and multiple triggering factors.
Takotsubo Cardiomyopathy 'Clustering': A Novel Observation Associated With an Unprecedented Flooding Event.
Regional wall motion abnormalities in critically ill patients: How frequent is takotsubo syndrome?
Tablet-based limited echocardiography at COVID-19-dedicated hospital during the pandemic in the context of takotsubo syndrome.
Ascending aortic aneurysm repair in the setting of Tako-tsubo cardiomyopathy.